Changes in Large Pulmonary Arterial Viscoelasticity in Chronic Pulmonary Hypertension

被引:47
|
作者
Wang, Zhijie [1 ]
Lakes, Roderic S. [1 ,2 ,3 ]
Golob, Mark [3 ]
Eickhoff, Jens C. [4 ]
Chesler, Naomi C. [1 ]
机构
[1] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA
[2] Univ Wisconsin, Dept Engn Phys, Madison, WI USA
[3] Univ Wisconsin, Dept Mat Sci, Madison, WI USA
[4] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA
来源
PLOS ONE | 2013年 / 8卷 / 11期
关键词
CHRONIC HYPOXIA; MECHANICAL-PROPERTIES; VENTRICULAR-FUNCTION; ELASTIC PROPERTIES; COLLAGEN-FIBERS; WAVE REFLECTION; CONSCIOUS DOGS; IN-VIVO; WALL; PRESSURE;
D O I
10.1371/journal.pone.0078569
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Conduit pulmonary artery (PA) stiffening is characteristic of pulmonary arterial hypertension (PAH) and is an excellent predictor of mortality due to right ventricular (RV) overload. To better understand the impact of conduit PA stiffening on RV afterload, it is critical to examine the arterial viscoelastic properties, which require measurements of elasticity (energy storage behavior) and viscosity (energy dissipation behavior). Here we hypothesize that PAH leads to frequency-dependent changes in arterial stiffness (related to elasticity) and damping ratio (related to viscosity) in large PAs. To test our hypothesis, PAH was induced by the combination of chronic hypoxia and an antiangiogenic compound (SU5416) treatment in mice. Static and sinusoidal pressure-inflation tests were performed on isolated conduit PAs at various frequencies (0.01-20 Hz) to obtain the mechanical properties in the absence of smooth muscle contraction. Static mechanical tests showed significant stiffening of large PAs with PAH, as expected. In dynamic mechanical tests, structural stiffness (kappa) increased and damping ratio (D) decreased at a physiologically relevant frequency (10 Hz) in hypertensive PAs. The dynamic elastic modulus (E), a material stiffness, did not increase significantly with PAH. All dynamic mechanical properties were strong functions of frequency. In particular, kappa, E and D increased with increasing frequency in control PAs. While this behavior remained for D in hypertensive PAs, it reversed for kappa and E. Since these novel dynamic mechanical property changes were found in the absence of changes in smooth muscle cell content or contraction, changes in collagen and proteoglycans and their interactions are likely critical to arterial viscoelasticity in a way that has not been previously described. The impact of these changes in PA viscoelasticity on RV afterload in PAH awaits further investigation.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] PHARMACOLOGICAL CHANGES IN PULMONARY CIRCULATION IN CHRONIC PULMONARY ARTERIAL-HYPERTENSION
    LARENG, L
    GENESTAL, M
    JORDA, MF
    CATHALA, B
    [J]. INTENSIVE CARE MEDICINE, 1977, 3 (03) : 202 - 202
  • [2] Pulmonary hypertension: evolution of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Anderson, Ryan J.
    Malhotra, Atul
    Kim, Nick H.
    [J]. JOURNAL OF THORACIC DISEASE, 2016, 8 : S562 - S565
  • [3] Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
    Humbert, M.
    [J]. EUROPEAN RESPIRATORY REVIEW, 2010, 19 (115): : 59 - 63
  • [4] Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Bishop, Bryan M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (21) : 1839 - 1844
  • [5] Pulmonary Artery Compliance in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: The Pulmonary Hypertension Association Registry
    McCormick, A.
    Krishnan, A.
    Badesch, D. B.
    Benza, R.
    Bull, T. M.
    De Marco, T.
    Feldman, J. P.
    Hemnes, A.
    Hirsch, R.
    Horn, E.
    Kennedy, J.
    Mathai, S. C.
    McConnell, J. W.
    Pugliese, S.
    Sager, J. S.
    Shlobin, O. A.
    Simon, M.
    Lammi, M. R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [6] RIOCIGUAT FOR THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
    Larche, N. E.
    Mousa, S. A.
    [J]. DRUGS OF TODAY, 2013, 49 (12) : 761 - 768
  • [7] Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Humbert, Marc
    Farber, Harrison W.
    Ghofrani, Hossein-Ardeschir
    Benza, Raymond L.
    Busse, Dennis
    Meier, Christian
    Hoeper, Marius M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (06)
  • [8] Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
    Koudstaal, Thomas
    Boomars, Karin A.
    Kool, Mirjam
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
  • [9] Invasive pulmonary artery pulsatility index in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Marinho, A.
    Baptista, R.
    Castro, G.
    Monteiro, P.
    Providencia, L. A.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 : 628 - 628
  • [10] Chronic pulmonary artery dissection associated with pulmonary arterial hypertension
    Cook, Rhonda
    Duarte, Alexander G.
    Boor, Paul
    Daniel, Cowan
    [J]. PULMONARY CIRCULATION, 2013, 3 (03) : 692 - 695